Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Herbert J. Kramer"'
Autor:
Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Zuzana Husková, Lenka Červenková, Soňa Kikerlová, Ivana Vaněčková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Petr Kujal, Herbert J. Kramer, Luděk Červenka
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 2, Pp 183-195 (2017)
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against progression of chronic kidney disease (CKD) in Ren-2
Externí odkaz:
https://doaj.org/article/069801b85c634eb1ad2d34b86397326b
Autor:
Herbert J. Kramer
Publikováno v:
Cardiovascular Complications of Liver Disease ISBN: 9781315138817
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74866124cbec442fb0f32bb0673ee0ee
https://doi.org/10.1201/9781315138817-14
https://doi.org/10.1201/9781315138817-14
Autor:
Herbert J Kramer
Publikováno v:
Frontiers in Endocrinology, Vol 6 (2015)
This brief review describes some representative methodological approaches to the isolation of putative endogenous inhibitors of epithelial sodium transport - i. e. as ouabain-like factors (OLF) that inhibit the sodium transport enzyme Na-K-ATPase or
Externí odkaz:
https://doaj.org/article/caded15b20d9468ea59c3cafb6b597b7
Autor:
Herbert J. Kramer, Petr Kujal, Lenka Červenková, Luděk Červenka, Soňa Kikerlová, Lenka Sedláková, Janusz Sadowski, Zuzana Husková, Věra Čertíková Chábová, Elzbieta Kompanowska-Jezierska, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Ivana Vaněčková
Publikováno v:
Clinical and Experimental Hypertension. 39:183-195
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against pr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::871f93b039cb8397ee0ba527b2f7db04
https://doi.org/10.1080/10641963.2016.1235184
https://doi.org/10.1080/10641963.2016.1235184
Autor:
Janusz Sadowski, Kento Kitada, Petra Škaroupková, Agnieszka Walkowska, Vera Certikova Chabova, Herbert J. Kramer, Akira Nishiyama, Petr Kujal, Sung H. Hwang, John D. Imig, Zuzana Husková, Zdena Vernerová, Bruce D. Hammock, Elzbieta Kompanowska-Jezierska, Ludek Cervenka
Publikováno v:
Clinical and experimental pharmacology & physiology, vol 41, iss 3
Clinical and Experimental Pharmacology & Physiology
Clinical and Experimental Pharmacology & Physiology
1. The aim of the present study was to test the hypothesis that increasing kidney tissue concentrations of epoxyeicosatrienoic acids (EETs) by preventing their degradation to the biologically inactive dihydroxyeicosatrienoic acids (DHETEs) using bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::310996bb99943331d219d2369b179310
https://doi.org/10.1111/1440-1681.12204
https://doi.org/10.1111/1440-1681.12204
Autor:
Šárka Jíchová, Janusz Sadowski, Zuzana Husková, Elzbieta Kompanowska-Jezierska, Libor Kopkan, John R. Falck, Herbert J. Kramer, Zdenka Vernerová, Petr Kujal, Luděk Červenka, Rami N. Reddy, Šárka Doleželová, Jan Neckář, John D. Imig
OBJECTIVE We evaluated the therapeutic effectiveness of a new, orally active epoxyeicosatrienoic acid analog (EET-A) in rats with angiotensin II (ANG II)-dependent malignant hypertension. METHODS Malignant hypertension was induced in Cyp1a1-Ren-2 tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a487f59fa61866faafe4bb44546130f
https://europepmc.org/articles/PMC5510029/
https://europepmc.org/articles/PMC5510029/
Autor:
Hsing Ju Tsai, Zuzana Honetschlägerová, John D. Imig, Alžběta Vojtíšková, Alexandra Sporková, Zuzana Husková, Bruce D. Hammock, Šárka Varcabová, Libor Kopkan, Petr Kujal, Herbert J. Kramer, Zdenka Vernerová, Sung Hee Hwang, Marcela Bürgelová, Luděk Červenka
Publikováno v:
Kidney and Blood Pressure Research. 35:595-607
Objective: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. Methods: Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e370117b6f826daeafdf97410846e59a
https://doi.org/10.1159/000339883
https://doi.org/10.1159/000339883
Autor:
Luděk Červenka, Petra Škaroupková, Zdeňka Vaňourková, Věra Čertíková Chábová, Petr Kujal, Zuzana Husková, Herbert J. Kramer, Zdenka Vernerová, Ivana Vaněčková, Vladimír Tesař
Publikováno v:
Kidney and Blood Pressure Research. 35:382-392
Our previous studies in rats with ablation nephrectomy have shown similar cardiorenal protective effects of renin-angiotensin system (RAS)-dependent treatment (combination of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4647a05a28e6be8e194af1e3fb5a862
https://doi.org/10.1159/000336823
https://doi.org/10.1159/000336823
Autor:
Herbert J. Kramer, Zdenka Vernerová, Věra Čertíková Chábová, Sung H. Hwang, Zuzana Husková, Zuzana Honetschlägerová, Luděk Červenka, Petr Kujal, Bruce D. Hammock, Vladimír Tesař, John D. Imig, Alexandra Sporková, Libor Kopkan
Publikováno v:
Journal of Hypertension. 29:1590-1601
In the present study, we compared the effects of treatment with the novel soluble epoxide hydrolase (sEH) inhibitor (c-AUCB) with those of the AT1 receptor antagonist losartan on blood pressure (BP), autoregulation of renal blood flow (RBF) and on gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9ac0bf061c5bcbc6599dd4e2d520fcd
https://doi.org/10.1097/hjh.0b013e328349062f
https://doi.org/10.1097/hjh.0b013e328349062f